References
- Junker N, Anderson M, Wenandy L, Dombernowsky S, Kiss K, Sorenson C, . Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinomas: a prerequisite for adoptive cell transfer. Cytotherapy. 2011; 13 [In press].
- Matta A, Ralhan R. Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma. Head Neck Oncol. 2009;1:6.
- Scully C, Bagan JV. Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes. Oral Oncol. 2009;45:e25–30.
- Straathof KC, Bollard CM, Popat U, Huls MH, Lopez T, Morriss MC, . Treatment of nasopharyngeal carcinoma with Epstein–Barr virus-specific T lymphocytes. Blood. 2005; 105:1898–904.
- Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, . Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein–Barr virus-targeted cytotoxic T lymphocytes. J Clin Oncol. 2005;23:8942–9.
- Louis CU, Straathof K, Bollard CM, Ennamuri S, Gerken C, Lopez TT, . Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother. 2010;33: 983–90.
- Goon PK, Stanley MA, Ebmeyer J, Steinstrasser L, Upile T, Jerjes W, . HPV and head and neck cancer: a descriptive update. Head Neck Oncol. 2009;1:36.
- Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer. 2008;8:299–308.
- Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, . Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008; 26:5233–9.
- Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, . Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 2006;314:126–9.
- Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, . Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood. 2009;114:535–46.
- Yannelli JR, Hyatt C, McConnell S, Hines K, Jacknin L, Parker L, . Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience. Int J Cancer. 1996;65:413–21.
- Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother. 2003;26:332–42.